倍他洛尔和普萘洛尔在胰高血糖素刺激生长激素分泌中的作用
Betaxolol and propranolol in glucagon stimulation of growth hormone.
作者信息
Colle M, Battin J, Coquelin J P, Rochiccioli P
出版信息
Arch Dis Child. 1984 Jul;59(7):670-2. doi: 10.1136/adc.59.7.670.
Abstract
Both betaxolol and propranolol, beta blockers with different pharmacological properties, increase the reliability of somatotropic testing with glucagon. The combination of glucagon and betaxolol, however, is much better tolerated than that of glucagon and propranolol. The use of a beta 1 cardioselective adrenoceptor block for growth hormone testing is recommended.
摘要
倍他洛尔和普萘洛尔这两种具有不同药理特性的β受体阻滞剂，均可提高胰高血糖素进行生长激素检测的可靠性。然而，胰高血糖素与倍他洛尔的组合比胰高血糖素与普萘洛尔的组合耐受性要好得多。推荐使用β1心脏选择性肾上腺素能受体阻滞剂进行生长激素检测。
相似文献
1
Betaxolol and propranolol in glucagon stimulation of growth hormone.倍他洛尔和普萘洛尔在胰高血糖素刺激生长激素分泌中的作用
Arch Dis Child. 1984 Jul;59(7):670-2. doi: 10.1136/adc.59.7.670.
2
[Study of somatotropic function by the betaxolol-glucagon test].[用倍他洛尔-胰高血糖素试验研究生长激素功能]
Presse Med. 1983 Jun 25;12(27):1729.
3
[Statistic study of 5,473 somatotropin secretion stimulation pharmacologic tests (n=9). Proposed weighting coefficient].5473例生长激素分泌刺激药理试验（n = 9）的统计研究。建议的加权系数
Ann Pediatr (Paris). 1993 Sep;40(7):391-5.
4
Growth hormone responses to propranolol-glucagon stimulation: a comparison with other tests of growth hormone reserve.生长激素对普萘洛尔-胰高血糖素刺激的反应：与其他生长激素储备测试的比较
J Clin Endocrinol Metab. 1973 Jul;37(1):85-92. doi: 10.1210/jcem-37-1-85.
5
Effect of cimetidine on the pharmacokinetics of the new beta-blocker betaxolol.
Arzneimittelforschung. 1987 Aug;37(8):953-6.
6
7
A comparative study of serum growth hormone and plasma cortisol levels in stimulation tests with insulin and propranolol-glucagon.胰岛素及普萘洛尔-胰高血糖素刺激试验中血清生长激素和血浆皮质醇水平的比较研究
Acta Endocrinol (Copenh). 1975 Sep;80(1):70-80. doi: 10.1530/acta.0.0800070.
8
Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension.倍他洛尔。对其药效学、药代动力学特性及在高血压治疗中的疗效的综述。
Drugs. 1986 Jan;31(1):6-28. doi: 10.2165/00003495-198631010-00002.
9
10
Comparison of pharmacological tests and 24-hour growth hormone secretion in 130 children with delayed growth.130例生长迟缓儿童的药理试验与24小时生长激素分泌的比较
Acta Paediatr Scand Suppl. 1987;337:72-3.
引用本文的文献
1
Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy.糖尿病心肌病的临床和实验治疗进展：关注当前和未来的治疗策略。
Front Endocrinol (Lausanne). 2024 Jul 30;15:1451100. doi: 10.3389/fendo.2024.1451100. eCollection 2024.
2
Pharmacokinetic study of metopimazine by oral route in children.口服甲哌啶嗪在儿童体内的药代动力学研究。
Pharmacol Res Perspect. 2015 Jun;3(3):e00130. doi: 10.1002/prp2.130. Epub 2015 Jun 1.
3
Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity.
J Endocrinol Invest. 1994 Dec;17(11):849-54. doi: 10.1007/BF03347790.
4
Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension.倍他洛尔。对其药效学、药代动力学特性及在高血压治疗中的疗效的综述。
Drugs. 1986 Jan;31(1):6-28. doi: 10.2165/00003495-198631010-00002.
本文引用的文献
1
Growth hormone responses to propranolol-glucagon stimulation: a comparison with other tests of growth hormone reserve.生长激素对普萘洛尔-胰高血糖素刺激的反应：与其他生长激素储备测试的比较
J Clin Endocrinol Metab. 1973 Jul;37(1):85-92. doi: 10.1210/jcem-37-1-85.
Zotero 插件